257 related articles for article (PubMed ID: 21880540)
1. Prognostic value of DNA ploidy status in patients with oral leukoplakia.
Bremmer JF; Brakenhoff RH; Broeckaert MA; Beliën JA; Leemans CR; Bloemena E; van der Waal I; Braakhuis BJ
Oral Oncol; 2011 Oct; 47(10):956-60. PubMed ID: 21880540
[TBL] [Abstract][Full Text] [Related]
2. Chromosome instability predicts the progression of premalignant oral lesions.
Siebers TJ; Bergshoeff VE; Otte-Höller I; Kremer B; Speel EJ; van der Laak JA; Merkx MA; Slootweg PJ
Oral Oncol; 2013 Dec; 49(12):1121-8. PubMed ID: 24075955
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
[TBL] [Abstract][Full Text] [Related]
4. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia.
Sudbø J; Bryne M; Johannessen AC; Kildal W; Danielsen HE; Reith A
J Pathol; 2001 Jul; 194(3):303-10. PubMed ID: 11439362
[TBL] [Abstract][Full Text] [Related]
5. High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia.
Gouvêa AF; Santos Silva AR; Speight PM; Hunter K; Carlos R; Vargas PA; de Almeida OP; Lopes MA
Histopathology; 2013 Mar; 62(4):551-62. PubMed ID: 23347057
[TBL] [Abstract][Full Text] [Related]
6. DNA content as a prognostic marker in patients with oral leukoplakia.
Sudbø J; Kildal W; Risberg B; Koppang HS; Danielsen HE; Reith A
N Engl J Med; 2001 Apr; 344(17):1270-8. PubMed ID: 11320386
[TBL] [Abstract][Full Text] [Related]
7. The influence of resection and aneuploidy on mortality in oral leukoplakia.
Sudbø J; Lippman SM; Lee JJ; Mao L; Kildal W; Sudbø A; Sagen S; Bryne M; El-Naggar A; Risberg B; Evensen JF; Reith A
N Engl J Med; 2004 Apr; 350(14):1405-13. PubMed ID: 15070790
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy measurement in oral leukoplakia: different results between flow and image cytometry.
Brouns ER; Bloemena E; Belien JA; Broeckaert MA; Aartman IH; van der Waal I
Oral Oncol; 2012 Jul; 48(7):636-40. PubMed ID: 22342568
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression.
Torres-Rendon A; Stewart R; Craig GT; Wells M; Speight PM
Oral Oncol; 2009 Jun; 45(6):468-73. PubMed ID: 18805043
[TBL] [Abstract][Full Text] [Related]
10. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings.
Saito T; Yamashita T; Notani K; Fukuda H; Mizuno S; Shindoh M; Amemiya A
Int J Oral Maxillofac Surg; 1995 Feb; 24(1 Pt 1):44-7. PubMed ID: 7782640
[TBL] [Abstract][Full Text] [Related]
12. DNA analysis of oral leukoplakia by flow cytometry.
Saito T; Notani K; Miura H; Fukuda H; Mizuno S; Shindoh M; Amemiya A
Int J Oral Maxillofac Surg; 1991 Oct; 20(5):259-63. PubMed ID: 1761874
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy in proliferative verrucous leukoplakia.
Klanrit P; Sperandio M; Brown AL; Shirlaw PJ; Challacombe SJ; Morgan PR; Odell EW
Oral Oncol; 2007 Mar; 43(3):310-6. PubMed ID: 16931117
[TBL] [Abstract][Full Text] [Related]
14. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
15. S-phase fraction and DNA ploidy in oral leukoplakia.
Khanna R; Agarwal A; Khanna S; Basu S; Khanna AK
ANZ J Surg; 2010; 80(7-8):548-51. PubMed ID: 20795971
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of oral precancerous lesions].
Sudbø J; Warloe T; Aamdal S; Reith A; Bryne M
Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3066-71. PubMed ID: 11757442
[TBL] [Abstract][Full Text] [Related]
17. Tobacco use increase the number of aneuploid nuclei in the clinically healthy oral epithelium.
Souto GR; Caliari MV; Lins CE; de Aguiar MC; de Abreu MH; Mesquita RA
J Oral Pathol Med; 2010 Sep; 39(8):605-10. PubMed ID: 20618610
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal instability, DNA index, dysplasia, and subsite in oral premalignancy as intermediate endpoints of risk of cancer.
Giaretti W; Monteghirfo S; Pentenero M; Gandolfo S; Malacarne D; Castagnola P
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1133-41. PubMed ID: 23629518
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
